Citation Impact
Citing Papers
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
2015
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
2016 Standout
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
2013 StandoutNobel
Bile acid transporters and regulatory nuclear receptors in the liver and beyond
2012
Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury
2015
Atypical hemolytic uremic syndrome
2011
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Investigating mechanisms of chronic kidney disease in mouse models
2011
Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis
2015 Standout
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
2021 StandoutNobel
Autoimmune forms of thrombotic micorangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles
2009
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
Genetics and Outcome of Atypical Hemolytic Uremic Syndrome
2013
Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome
2013
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Nosocomial Tuberculosis: New Progress in Control and Prevention
1995
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
2012
Complement as a diagnostic tool in immunopathology
2018
Complement in human diseases: Lessons from complement deficiencies
2009
Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity
2010
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
2013
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
2012
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
2020 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Biological roles of glycans
2016 Standout
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Zeaxanthin induces Nrf2-mediated phase II enzymes in protection of cell death
2014
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
1998
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
2010
Age-related macular degeneration
2018 Standout
MicroRNAs in liver disease
2013
TFOS DEWS II Management and Therapy Report
2017 Standout
Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement Regulation
2015
The cost-effectiveness of placing urinary tract infection treatment over the counter
1996
Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy
2017 Standout
Urinary Tract Infection
2000 Standout
Mice with a Targeted Disruption of the AE2 Cl − / HCO 3 −
2004
Sensors and regulators of intracellular pH
2009 Standout
Shiga Toxin Associated Hemolytic Uremic Syndrome
2015
Risk factors and biomarkers of age-related macular degeneration
2016
Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
2013
Oral Antibiotics for Meibomian Gland-Related Ocular Surface Disease
2015
Structural basis for sialic acid–mediated self-recognition by complement factor H
2014
The spectrum of complement alternative pathway‐mediated diseases
2008
Diversity of structures and properties among catalases
2004 Standout
Neuroinflammation: the devil is in the details
2016 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
The biological cost of antibiotic resistance
1999 Standout
The Complement Inhibitors Crry and Factor H Are Critical for Preventing Autologous Complement Activation on Renal Tubular Epithelial Cells
2010
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
1995
Bicarbonate transport in cell physiology and disease
2008
Molecular physiology and genetics of Na+-independent SLC4 anion exchangers
2009
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family
1996
rpoB -Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria
2003 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
2014
The Continuing Challenges of Leprosy
2006 Standout
Works of Sergio Recalde being referenced
Ae2-Deficient Mice Develop Antimitochondrial Antibodies and Other Features Resembling Primary Biliary Cirrhosis
2008
Effect of Zeaxanthin and Antioxidant Supplementation on Vascular Endothelial Growth Factor (VEGF) Expression in Apolipoprotein-E Deficient Mice
2009
Trends in the Susceptibility of Tuberculosis in New York City, 1987-1991
1994
Inefficient Chronic Activation of Parietal Cells in Ae2−/− Mice
2006
Anion exchanger 2 is essential for spermiogenesis in mice
2003
Azithromycin reduces inflammation in a rat model of acute conjunctivitis.
2013
Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains
2007
Growth of Geographic Atrophy on Fundus Autofluorescence and Polymorphisms ofCFH,CFB,C3,FHR1-3, andARMS2in Age-Related Macular Degeneration
2014
Relevance of Complement Factor H–Related 1 (CFHR1) Genotypes in Age-Related Macular Degeneration
2012